Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Martina Šterclová"'
Autor:
Martina Sterclova, Martina Doubkova, Lubica Sykorova, Vladimir Bartos, Monika Zurkova, Vladimira Lostakova, Radka Mokosova, Martina Plackova, Ladislav Lacina, Michaela Cimrova, Radka Bittenglova, Pavlina Lisa, Pavla Musilova, Daniel Dolezal, Jana Psikalova, Petra Ovesna, Martina Koziar Vasakova
Publikováno v:
Pulmonary Medicine, Vol 2024 (2024)
There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim of the present study was to assess adherence to the consensus of the International Society
Externí odkaz:
https://doaj.org/article/94d509ca7d934c66ba732b7f4a1dc771
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Background Extrinsic allergic alveolitis (EAA) patients form heterogenous group with different clinical manifestation and different prognosis. We aimed to determine how to phenotype distinct EAA subgroups. Predictive role of the bronchoalveo
Externí odkaz:
https://doaj.org/article/b5b96741704142cfb4659a115a8f9621
Autor:
Monika Zurkova, Eva Kriegova, Vitezslav Kolek, Vladimira Lostakova, Martina Sterclova, Vladimir Bartos, Martina Doubkova, Ilona Binkova, Michal Svoboda, Jana Strenkova, Marketa Janotova, Martina Plackova, Ladislav Lacina, Vladimir Rihak, Frantisek Petrik, Pavlina Lisa, Radka Bittenglova, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Psikalova, Tomas Snizek, Jiri Homolka, Renata Kralova, Jan Kervitzer, Martina Vasakova, ILD section, IPF registry
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Introduction Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the decline of lung function and overall survival (OS) in real-world cohorts on
Externí odkaz:
https://doaj.org/article/eb20517990ed4ee998a6eafe220aaf34
Autor:
Martina Sterclova, Veronika Kremlackova, Veronika Mottlova, Magdalena Bruzova, Pavel Sojka, Martina Vasakova
Publikováno v:
Cogent Medicine, Vol 8, Iss 1 (2021)
Abstract: Assessment of humoral response to inhalation antigens is currently the most frequently used method to confirm exposure. It may be useful in extrinsic allergic alveolitis (EAA) patients, especially in cases that are unaware of the source of
Externí odkaz:
https://doaj.org/article/b4a654353bc741b7be6cb2fc5d180bc5
Publikováno v:
Diagnostics, Vol 11, Iss 4, p 693 (2021)
Idiopathic interstitial pneumonia (IIP) entails a variable group of lung diseases of unknown etiology. Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, interstitial lung diseases related to connective tissue disease (CTD-ILD), and h
Externí odkaz:
https://doaj.org/article/983b3b2376d5418ead04d0a12dd3a6d9
Autor:
Marianna Štefániková, Martina Doubková, Petra Ovesná, Martina Šterclová, Ladislav Lacina, Monika Žurková, Martina Plačková, Vladimír Bartoš, Ivana Janíčková, Radka Bittenglová, Jan Anton, Ľubica Sýkorová, Vladimíra Lošťáková, Pavlína Musilová, Hana Šuldová, Radka Mokošová, Jurij Didyk, Lenka Šišáková, Pavlína Lisá, Jaroslav Lněnička, Hana Dařičková, Daniel Doležel, Jana Pšikalová, Richard Tyl, Renata Králová, Martina Koziar Vašáková
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Introduction The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic treatment outcome in real-world cohorts of Czech EMPIRE registry. Patients/m
Externí odkaz:
https://doaj.org/article/354e93acae574d0789b4d40b679b4189
Autor:
Dragana M. Jovanovic, Martina Šterclová, Nesrin Mogulkoc, Katarzyna Lewandowska, Veronika Müller, Marta Hájková, Michael Studnicka, Jasna Tekavec-Trkanjec, Simona Littnerová, Martina Vašáková, the EMPIRE registry investigators
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple comorbidities, which may influence survival but go under-recognised in clinical practice. We therefore report comorbidity, antifibrotic treatment use and s
Externí odkaz:
https://doaj.org/article/3e8acd4648c840be8bf8eb43046c6c69
Autor:
Tanja Tran, Martina Šterclová, Nesrin Mogulkoc, Katarzyna Lewandowska, Veronika Müller, Marta Hájková, Mordechai R. Kramer, Dragana Jovanović, Jasna Tekavec-Trkanjec, Michael Studnicka, Natalia Stoeva, Karel Hejduk, Ladislav Dušek, Samy Suissa, Martina Vašáková, for the EMPIRE registry
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of follow-up are limited. Here, we describe the large European MultiPartner I
Externí odkaz:
https://doaj.org/article/9d4a56a4f4404f718e7719bee03526fd
Autor:
Ondřej Májek, Jakub Gregor, Nesrin Mogulkoć, Katarzyna Lewandowska, Martina Šterclová, Veronika Müller, Marta Hájková, Mordechai R Kramer, Jasna Tekavec-Trkanjec, Dragana Jovanović, Michael Studnicka, Natalia Stoeva, Klaus-Uwe Kirchgässler, Simona Littnerová, Ladislav Dušek, Martina Koziar Vašáková
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0273854 (2022)
BackgroundThere is no clear evidence whether pirfenidone has a benefit in patients with probable or possible UIP, i.e. when idiopathic pulmonary fibrosis (IPF) is diagnosed with a lower degree of diagnostic certainty. We report on outcomes of treatme
Externí odkaz:
https://doaj.org/article/62d03fd7fced4bb68c72565e31432e8a
Autor:
Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Mogulkoc, Katarzyna Lewandowska, Veronika Müller, Marta Hájková, Mordechai Kramer, Dragana Jovanovic, Jasna Tekavec-Trkanjec, Michael Studnicka, Natalia Stoeva, Simona Littnerová, Martina Vašáková
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Idiopathic pulmonary fibrosis (IPF) is a rare lung disease with poor prognosis. The diagnosis and treatment possibilities are dependent on the health systems of countries. Hence, comparison among countries is difficult due to data heterogeneity. Our
Externí odkaz:
https://doaj.org/article/b399851ef6f24b1fa825cc97e6b8ce39